"RethinkBH and Raintree are combining our strengths to deliver tools that meet the real-world needs of multidisciplinary therapy practices," said Rethink CEO Ben Semmes. "We want to make life easier ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Data Commun Management ( (TSE:DCM)) has ...

Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs ...

Extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) have become a critical global public health challenge due to their high resistance to β-lactam antibiotics and association with severe ...

The report highlights market opportunities by offering strategic insights into global rhabdomyosarcoma clinical trials. Key opportunities include identifying optimal locations for trials, ...

ORR in heavily pre-treated patients with MSS mCRC without liver metastases and with high plasma tumor mutational burden (TMB) Estimate 55% of patients with MSS CRC have high plasma TMB, representing a ...

Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a ...

Key market opportunities include strategic investment in Idiopathic Pulmonary Fibrosis trials, optimizing trial locations to reduce costs, and leveraging top-level data for strategic planning.

ORR in heavily pre-treated patients with MSS mCRC without liver metastases and with high plasma tumor mutational burden (TMB)Estimate 55% of ...

WASHINGTON (Reuters) -The White House said on Friday there likely will not be a release of inflation data next month due to the U.S. government shutdown. Because of Congress' failure to pass a stopgap ...

Jay will begin with a review of recent corporate updates and discuss our clinical programs for DuraVu in wet AMD and DME.

NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) ("WeightWatchers,” "WW,” or the "Company”) today announced its results for the third quarter of fiscal 2025 ended ...